ARCHIVES

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

This article is from The Cancer Letter archive.

Vol. 31 No. 19 | May 13, 2005

Download PDF Visit The Full Archive

Related Articles

RF Numbers To Drop Noticeably Soon, Upton Tells AACR

April 14, 1978

PSA Level Predicts Survival For Prostate Cancer

October 25, 2002

NIH Director Collins Publishes Third Book About Faith In God

March 5, 2010

DePinho Seeks Broad Waiver From COI Policy To Cover Financial Ties With 12 Entities

September 21, 2012

Dial Access Offers Caner Consultation Services

February 21, 1975

In this 16-page issue: The Wall Street Journal editorial page leads campaign against efficacy standard.

August 5, 2005